Using the median of PCR results, we divided patients with high and low expression of KDM5D in clinical specimens into groups and found that KDM5D was poorly expressed in CRC, and its low expression conveyed poor prognosis in patients with CRC (P = 0.009, Fig. 6B). Here, KDM5D is linked to colorectal carcinoma.